Magenta therapeutics announces collaboration with the national marrow donor program

Magenta therapeutics announces collaboration with the national marrow donor program/be the match to advance development of mgta-145 for first-line mobilization of stem cells from healthy donors and subsequent patient transplant.magenta therapeutics inc - plan to initiate a phase ii trial of mgta-145 in matched related donors for patients undergoing allogeneic transplant.magenta therapeutics - collaboration focuses on clinical development of mgta-145 for stem cell mobilization in allogeneic transplant.magenta therapeutics inc - magenta will retain all commercial rights to mgta-145.
DNTH Ratings Summary
DNTH Quant Ranking